RGT 8.18% 50.5¢ argent biopharma limited

Ann: Notice of General Meeting/Proxy Form, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,175 Posts.
    lightbulb Created with Sketch. 1443
    LOL
    Of course this is reasonable.
    Translation: "arms length" = "reacharound"

    "The Directors (other than Mr Zomer who has a material personal interest in the
    Resolution) consider that Shareholder approval pursuant to Chapter 2E of the
    Corporations Act is not required in respect of the grant of Shares because the agreement to issue the Shares, reached as part of the remuneration package for Mr Zomer, is considered reasonable remuneration in the circumstances and was negotiated on an arm’s length basis."

    "(f) the purpose of the issue of the Shares is to provide a performance linked
    incentive component in the remuneration package for Roby Zomer to
    motivate and reward his performance as a Director and to provide cost
    effective remuneration to Mr Zomer, enabling the Company to spend a greater proportion of its cash reserves on its operations than it would if alternative cash forms of remuneration were given to Mr Zomer;

    (g) the current total remuneration package for Roby Zomer is $365,683, comprising Director’s salary. If the Shares are issued, the total remuneration package of Mr Zomer will increase by $1,120,000 to $1,485,683, being the value of the Shares based on the closing price as at 26 July 2024;"
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.